Gene · 6091
Papers2,184
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,184
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential. | Exp Hematol Oncol | 2022 | 36324149 | PubTator, text mining | PubMed |
| A review of therapeutic potentials of milk thistle (Silybum marianum L.) and its main constituent, silymarin, on cancer, and their related patents. | Iran J Basic Med Sci | 2022 | 36311193 | PubTator, text mining | PubMed |
| Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer. | Int J Mol Sci | 2022 | 36293239 | PubTator, text mining | PubMed |
| Tumor-Derived Exosomal miR-29b Reduces Angiogenesis in Pancreatic Cancer by Silencing ROBO1 and SRGAP2. | J Immunol Res | 2022 | 36277474 | PubTator, text mining | PubMed |
| Global mapping of GalNAc-T isoform-specificities and O-glycosylation site-occupancy in a tissue-forming human cell line. | Nat Commun | 2022 | 36270990 | PubTator, text mining | PubMed |
| Discovery of 42 genome-wide significant loci associated with dyslexia. | Nat Genet | 2022 | 36266505 | PubTator, text mining | PubMed |
| Role of microRNAs in trophoblast invasion and spiral artery remodeling: Implications for preeclampsia. | Front Cell Dev Biol | 2022 | 36263015 | PubTator, text mining | PubMed |
| Tumor buster - where will the CAR-T cell therapy 'missile' go? | Mol Cancer | 2022 | 36261831 | PubTator, text mining | PubMed |
| RNA m6A reader IGF2BP3 promotes metastasis of triple-negative breast cancer via SLIT2 repression. | FASEB J | 2022 | 36250924 | PubTator, text mining | PubMed |
| Novel genes and variants associated with congenital pituitary hormone deficiency in the era of next-generation sequencing. | Front Endocrinol (Lausanne) | 2022 | 36237189 | PubTator, text mining | PubMed |
| Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters. | Int J Mol Sci | 2022 | 36232719 | PubTator, text mining | PubMed |
| Tumor immune cell infiltration score based model predicts prognosis in multiple myeloma. | Sci Rep | 2022 | 36224246 | PubTator, text mining | PubMed |
| Orthographic Depth May Influence the Degree of Severity of Maze Learning Performance in Children at Risk for Reading Disorder. | Dev Neurosci | 2022 | 36223729 | PubTator, text mining | PubMed |
| Genome-wide association study for Chagas Cardiomyopathy identify a new risk locus on chromosome 18 associated with an immune-related protein and transcriptional signature. | PLoS Negl Trop Dis | 2022 | 36215317 | PubTator, text mining | PubMed |
| From protein-protein interactions to immune modulation: Therapeutic prospects of targeting Neuropilin-1 in high-grade glioma. | Front Immunol | 2022 | 36203599 | PubTator, text mining | PubMed |
| Bioinformatic identification of differentially expressed genes associated with hepatocellular carcinoma prognosis. | Medicine (Baltimore) | 2022 | 36197270 | PubTator, text mining | PubMed |
| Circular RNAs in Diabetic Nephropathy: Updates and Perspectives. | Aging Dis | 2022 | 36186139 | PubTator, text mining | PubMed |
| Immunoregulation and clinical significance of neutrophils/NETs-ANGPT2 in tumor microenvironment of gastric cancer. | Front Immunol | 2022 | 36172371 | PubTator, text mining | PubMed |
| Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma. | Signal Transduct Target Ther | 2022 | 36167691 | PubTator, text mining | PubMed |
| Nanomedicine approaches for treatment of hematologic and oncologic malignancies. | World J Clin Oncol | 2022 | 36157164 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6091/papers?page=19